Chemotherapy And Tamoxifen Reduce Risk Of Second Breast Cancer, Study Finds
ScienceDaily (Dec. 27, 2007) — Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online December 25 in the Journal of the National Cancer Institute. The risk reduction persisted for at least 10 and 5 years, respectively.
For breast cancer patients the risk of developing cancer in the other breast is two to six times greater than the breast cancer risk of the general public. Studies have shown that taking tamoxifen for five years reduces the risk of cancer in the opposite breast among women who have estrogen receptor-positive breast cancer, but the studies did not clarify how long the protective effect lasts. Read more
Breast Asymmetry Predicts Breast Cancer
ScienceDaily (Mar. 20, 2006) — Women who go on to develop breast cancer tend to have breasts that are less symmetrical than women who don’t develop the cancer. A study published in Breast Cancer Research reveals that breast asymmetry could be a reliable independent predictor of breast cancer.
The study found that the relative odds of developing breast cancer increased by 1.5 with each 100ml increase in breast asymmetry. Read more
Breast Asymmetry Predicts Breast Cancer
The study found that the relative odds of developing breast cancer increased by 1.5 with each 100ml increase in breast asymmetry.
Diane Scutt from the University of Liverpool, UK and colleagues studied the mammograms of 252 women who did not have breast cancer at the time of the mammography, but later on developed the disease. The control group consisted of 252 women matched for age who underwent mammography at the same time, but did not develop breast cancer. Read more